Iteos Therapeutics Inc Financial Flexibility Index
Iteos Therapeutics Inc financial flexibility index. Iteos Therapeutics Inc (ITOS) has a Financial Flexibility Index of -0.33x as of June 2025. Free cash flow of $-42.16 Million (operating CF $-42.45 Million minus capex $283.00K) represents 0% of total liabilities ($129.28 Million). See Iteos Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Iteos Therapeutics Inc (2018–2024)
Financial flexibility index of Iteos Therapeutics Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Iteos Therapeutics Inc across 7 annual periods. Check Iteos Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Iteos Therapeutics Inc Financial Flexibility Index by Year (2018–2024)
Iteos Therapeutics Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Iteos Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Iteos Therapeutics Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-96.55 Million | $-98.18 Million | $96.68 Million | ▲ +8.5% |
| 2023 | -1.09x | $-100.79 Million | $-103.76 Million | $92.36 Million | ▲ +9.3% |
| 2022 | -1.20x | $-110.25 Million | $-111.19 Million | $91.66 Million | ▼ -177.6% |
| 2021 | 1.55x | $514.32 Million | $513.14 Million | $331.89 Million | ▲ +233.4% |
| 2020 | -1.16x | $-24.82 Million | $-25.18 Million | $21.36 Million | ▲ +21.9% |
| 2019 | -1.49x | $-22.42 Million | $-23.14 Million | $15.07 Million | ▲ +2.7% |
| 2018 | -1.53x | $-18.87 Million | $-19.10 Million | $12.34 Million | — |